THC Therapeutics (THC Therapeutics) FCF Margin % : 0.00% (As of Jul. 2023)

View and export this data going back to 2007. Start your Free Trial

What is THC Therapeutics FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. THC Therapeutics's Free Cash Flow for the three months ended in Jul. 2023 was $0.00 Mil. THC Therapeutics's Revenue for the three months ended in Jul. 2023 was $0.00 Mil. Therefore, THC Therapeutics's FCF Margin % for the quarter that ended in Jul. 2023 was 0.00%.

As of today, THC Therapeutics's current FCF Yield % is -96.46%.

The historical rank and industry rank for THC Therapeutics's FCF Margin % or its related term are showing as below:

THCT's FCF Margin % is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 0.29
* Ranked among companies with meaningful FCF Margin % only.

THC Therapeutics FCF Margin % Historical Data

The historical data trend for THC Therapeutics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

THC Therapeutics FCF Margin % Chart

THC Therapeutics Annual Data

Trend

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

FCF Margin %

Get a 7-Day Free Trial

THC Therapeutics Quarterly Data
	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of THC Therapeutics's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, THC Therapeutics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

THC Therapeutics's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, THC Therapeutics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where THC Therapeutics's FCF Margin % falls into.

THC Therapeutics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

THC Therapeutics's FCF Margin for the fiscal year that ended in Jul. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Jul. 2023 )	/	Revenue (A: Jul. 2023 )
	=	-0.085	/	0
	=	%

THC Therapeutics's FCF Margin for the quarter that ended in Jul. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Jul. 2023 )	/	Revenue (Q: Jul. 2023 )
	=	0	/	0
	=	%

THC Therapeutics FCF Margin % Related Terms

Thank you for viewing the detailed overview of THC Therapeutics's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

THC Therapeutics (THC Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » THC Therapeutics Inc (OTCPK:THCT) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

11700 W Charleston Boulevard, No. 73, Las Vegas, NV, USA, 89135

Website

https://thct.io

THC Therapeutics Inc is a United States-based company. It is focused on developing dHydronator, a sanitizing herb dryer. The main function of the dHydronator is to accelerate the drying time of an herb while sanitizing it. The dHydronator can be used to dry a variety of herbs, and it has been specifically tested for use with cannabis. It will reduce the drying time for cannabis from 10-14 days down to less than 14 hours.

Executives

Hiro Tanaka	director, officer: Vice President	3RD FLOOR, 207 REGENT STREET, LONDON X0 W1B 3HH
Smith Adrian J R	director, officer: Chair of the Board	119 SPRINGLINE DRIVE, VERO BEACH FL 32963
Jamie Mann	director, 10 percent owner, officer: CEO, CFO	3RD FLOOR, 207 REGENT STREET, LONDON X0 W1B 3HH
Eden Ho	director, officer: CEO	701 XUANG MI HU ROAD, XI YUAN, FUTIAN, SHENZHEN F4 XXXXXX